It’s not about hearing. It’s about truly listening to patients to find new ways of improving dermatology care.
LEO Pharma is the world’s leading speciality pharma company, focused on improving the lives of people living with dermatologic (skin) and thromboembolic (blood clotting) conditions. By listening to people with skin conditions, LEO Pharma develops complete care solutions that meet patient needs.
LEO Pharma is wholly owned by The LEO Foundation and the company is headquartered in Ballerup, Denmark, outside of Copenhagen, and is represented in more than 100 countries worldwide.
We are around 5,000 specialized employees globally working to develop, produce and market our drugs. The organization is scalable and flexible, giving us plenty of opportunities for cross-disciplinary collaboration across the entire company. We share knowledge, ideas and skills that enable us to pursue innovative approaches, adopt new technologies and quickly adapt to new conditions. Through the international, scientific networks across the LEO Pharma companies, we constantly work to optimise the synergies of a global company.
We don’t develop medical treatments – instead, we look at all the aspects of everyday life that can affect a person who has a skin condition. The solutions are focused primarily on e-health and add-on devices.
LEO Innovation Lab has been established as a separate entity to create a smaller, more agile organization, where innovation can thrive and solutions can be brought to market and tested faster.
As LEO Pharma is owned entirely by The LEO Foundation and has no shareholders, its profits are reinvested in developing new solutions to support the overall mission: to help people achieve healthy skin. This unique ownership structure has made it possible to establish LEO Innovation Lab with a goal of making a difference to people living with a skin condition.
LEO Innovation Lab develops digital solutions and services such as apps, digital platforms and other initiatives to support people with psoriasis across all aspects of their lives – including: diet and nutrition, health and beauty, family issues, and mental health.
Get a personal nutrition coach to assist you in transforming your diet which may help calm the inflammation that can contribute to your symptoms.
A collaboration with The Happiness Research Institute. We explore how psoriasis impacts quality of life and levels of happiness with a view to raise awareness, address stigma and build a community of support.
Alba’s Post helps you explore the relationship between psoriasis and foods to better cope with your disease. Inclusive research on external factors – tried and tested by real people.
InTouch allows patients to have consultations with medical experts through video or text to receive treatment, advice and prescriptions.
The hub has its focus on LEO Pharma’s need for breakthrough innovation. The unique structure of the Hub will allow for diverse partnerships with academic institutions, biotech companies and venture capital firms. All which will be used to strengthen our innovation projects.
LEO Science & Tech Hub is a team of senior scientists situated in the heart of the Cambridge innovation ecosystem in Massachusetts, USA. The team has been created as a separate and agile entity to support breakthrough innovation and help LEO Pharma bring new solutions to patients, faster.
We explore cutting-edge science and technology opportunities with relevance to dermatology. By partnering with public and private institutions, the LEO Science & Tech Hub acts as a catalyst that transforms early-stage innovations and technologies into solutions that will improve the quality of life for people with skin diseases. LEO Science & Tech Hub is part of LEO Pharma, a global healthcare company dedicated to helping people achieve healthy skin.